Accelerate Diagnostics Inc (AXDX):企業の財務・戦略的SWOT分析

◆英語タイトル:Accelerate Diagnostics Inc (AXDX) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME18328FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年3月
◆ページ数:45
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Accelerate Diagnostics Inc (AXDX) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Accelerate Diagnostics Inc (Accelerate) is an in vitro diagnostics company that carries out the development and commercialization of instruments for the identification and testing of antibiotic susceptibility of infectious pathogens. Its product portfolio includes Accelerate Pheno system, a platform for the identification (ID) and antibiotic susceptibility testing (AST) of infectious pathogens; and Accelerate PhenoTest BC kit which provides ID and AST results for patients with bacteremia or fungemia. The company has a manufacturing facility in Tucson Arizona. It sells products directly and also through a network of third-party distributors to hospital microbiology laboratories in domestic and foreign countries. Accelerate is headquartered in Tucson, Arizona, the US.

Accelerate Diagnostics Inc Key Recent Developments

Feb 23,2021: Accelerate Diagnostics reports fourth quarter and full-year 2020 financial results
Feb 01,2021: Accelerate Diagnostics schedules call to review 2020 fourth quarter and full year results
Jan 12,2021: Accelerate Diagnostics announces preliminary fourth quarter and full-year 2020 financial results
Nov 05,2020: Accelerate Diagnostics reports third quarter 2020 financial results
Aug 24,2020: Accelerate Diagnostics names Nedal Safwat chief strategy officer

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Accelerate Diagnostics Inc – Key Facts
Accelerate Diagnostics Inc – Key Employees
Accelerate Diagnostics Inc – Key Employee Biographies
Accelerate Diagnostics Inc – Major Products and Services
Accelerate Diagnostics Inc – History
Accelerate Diagnostics Inc – Company Statement
Accelerate Diagnostics Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Accelerate Diagnostics Inc – Business Description
Geographical Segment: Domestic
Performance
Geographical Segment: Foreign
Performance
R&D Overview
Accelerate Diagnostics Inc – SWOT Analysis
SWOT Analysis – Overview
Accelerate Diagnostics Inc – Strengths
Accelerate Diagnostics Inc – Weaknesses
Accelerate Diagnostics Inc – Opportunities
Accelerate Diagnostics Inc – Threats
Accelerate Diagnostics Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Accelerate Diagnostics Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Accelerate Diagnostics Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
Accelerate Diagnostics Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 23, 2021: Accelerate Diagnostics reports fourth quarter and full-year 2020 financial results
Feb 01, 2021: Accelerate Diagnostics schedules call to review 2020 fourth quarter and full year results
Jan 12, 2021: Accelerate Diagnostics announces preliminary fourth quarter and full-year 2020 financial results
Nov 05, 2020: Accelerate Diagnostics reports third quarter 2020 financial results
Aug 24, 2020: Accelerate Diagnostics names Nedal Safwat chief strategy officer
Aug 06, 2020: Accelerate Diagnostics reports second quarter 2020 financial results & announces new product offering
May 07, 2020: Accelerate Diagnostics Announces Preliminary First Quarter Financial Results and Provides COVID-19 Business Updates; Schedules First Quarter 2020 Financial Results Conference Call for May 7, 2020
Apr 15, 2020: Accelerate Diagnostics announces preliminary first quarter financial results and provides covid-19 business updates; schedules first quarter 2020
Apr 14, 2020: Accelerate Diagnostics receives loan under Paycheck Protection Program
Feb 27, 2020: Accelerate Diagnostics reports fourth quarter 2019 financial results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Accelerate Diagnostics Inc, Key Facts
Accelerate Diagnostics Inc, Key Employees
Accelerate Diagnostics Inc, Key Employee Biographies
Accelerate Diagnostics Inc, Major Products and Services
Accelerate Diagnostics Inc, History
Accelerate Diagnostics Inc, Subsidiaries
Accelerate Diagnostics Inc, Key Competitors
Accelerate Diagnostics Inc, Ratios based on current share price
Accelerate Diagnostics Inc, Annual Ratios
Accelerate Diagnostics Inc, Annual Ratios (Cont...1)
Accelerate Diagnostics Inc, Interim Ratios
Accelerate Diagnostics Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Accelerate Diagnostics Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
Accelerate Diagnostics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Accelerate Diagnostics Inc (AXDX):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • IFFCO-Tokio General Insurance Co. Ltd.:企業の戦略・SWOT・財務情報
    IFFCO-Tokio General Insurance Co. Ltd. - Strategy, SWOT and Corporate Finance Report Summary IFFCO-Tokio General Insurance Co. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Atlas Elektronik GmbH:企業の戦略・SWOT・財務情報
    Atlas Elektronik GmbH - Strategy, SWOT and Corporate Finance Report Summary Atlas Elektronik GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Sony Corp (6758):電力:M&Aディール及び事業提携情報
    Summary Sony Corporation (Sony) is a manufacturer of electronic equipment, semiconductors, medical related equipment, instruments, and devices. The company’s products comprises televisions, mobile phones, music systems, cameras, game consoles and software, semiconductors, batteries and other electro …
  • Bioqual Inc (BIOQ):企業の財務・戦略的SWOT分析
    Summary Bioqual Inc (Bioqual) is a provider of contract research services which focuses on in vivo models of human diseases such as AIDS, influenza, RSV infection flavivirus infections including zika and dengue, malaria, hepatitis and cancer. The company evaluates vaccines, vaccine therapeutics, mic …
  • Excelsior Gold Limited (EXG):企業の財務・戦略的SWOT分析
    Excelsior Gold Limited (EXG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Specialised Therapeutics Australia Pty Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Specialised Therapeutics Australia Pty Ltd (STA) is a biopharmaceutical company that develops and commercializes therapies and technologies for unmet medical needs. The company’s product portfolio includes abraxane, gliolan, oncotype dx, iclusig, oncotype dx prostate and aloxi. Its pipeline …
  • ShaMaran Petroleum Corp (SNM):企業の財務・戦略的SWOT分析
    Summary ShaMaran Petroleum Corp (ShaMaran Petroleum), formerly Bayou Bend Petroleum Ltd is an independent oil and gas exploration and development company. The corporation explores, produces, and develops oil and gas assets. It holds interests and operates Atrush petroleum property located in Kurdist …
  • Medrobotics Corp:企業の製品パイプライン分析2018
    Summary Medrobotics Corp (Medrobotics), formerly Cardioborobotics Inc, is a medical device company that manufactures and markets flexible robot platforms. The company provides Flex robotic system, a robot-assisted surgical platform that offers physicians with single-site access while operating in ha …
  • Pharma Two B Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Pharma Two B Ltd (Pharma Two) is a drug development company that develops and manufactures drugs for the treatment of Parkinson's disease and cancer. The company provides combination products in preclinical state and generic products including P2B 005, P2B 006, P2B 007, P2B 008 and P2B 009, …
  • Patterson Companies Inc (PDCO):医療機器:M&Aディール及び事業提携情報
    Summary Patterson Companies, Inc. (Patterson) is a distributor of dental and veterinary products, services and technologies. It provides products to the production and companion animal health markets. The company’s product portfolio comprises restorative materials, hand instruments, sterilization pr …
  • Gritstone Oncology Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Gritstone Oncology Inc (Gritstone) is a cancer immunotherapy company that focuses on the development of personalized cancer therapeutics. The company primarily concentrates on identifying and deploying the therapeutic neo-antigens from individual patients’ tumors for the development of novel …
  • Blount International, Inc.:企業の戦略的SWOT分析
    Blount International, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Schuco International KG:企業の戦略的SWOT分析
    Schuco International KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • SMART Technologies Inc.:企業の戦略的SWOT分析
    SMART Technologies Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Quadrise Fuels International Plc (QFI)-石油・ガス分野:企業M&A・提携分析
    Summary Quadrise Fuels International Plc (QFI), formerly Zareba Plc, is an oil-in-water emulsified fuel developer that manufactures and markets MSAR (Multiphase Superfine Atomised Residue), an emulsion fuel as a low cost substitute for conventional heavy fuel oil (HFO) for use in power generation pl …
  • XERIS Pharmaceuticals Inc (XERS):製薬・医療:M&Aディール及び事業提携情報
    Summary XERIS Pharmaceuticals Inc (XERIS) is a specialty pharmaceutical company that develops and commercializes injectable and infusible drug formulations. The company’s proprietary XeriSol and XeriJect formulation technologies allow for the subcutaneous and intramuscular delivery of ultra concentr …
  • Vexim SA (ALVXM):企業の財務・戦略的SWOT分析
    Summary Vexim SA (Vexim), a subsidiary of Stryker Corp, is a healthcare product manufacturer that provides solutions for patients suffering from vertebral compression fractures. The company provides solutions such as controlled anatomical restoration and advanced vertebroplasty therapy. Its controll …
  • Micron Technology Inc:戦略・SWOT・企業財務分析
    Micron Technology Inc - Strategy, SWOT and Corporate Finance Report Summary Micron Technology Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Attunity Ltd (ATTU):企業の財務・戦略的SWOT分析
    Summary Attunity Ltd (Attunity) is a technology company that provides data management software, cloud database replication solutions, and google cloud database tools. The company provides data management software solutions that enable access, sharing, management, and distribution of data. It offers …
  • Dynegy Inc:発電所・企業SWOT分析
    Dynegy Inc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆